Skip to main content
. 2010 Jun;100(6):1075–1080. doi: 10.2105/AJPH.2009.178491

FIGURE 4.

FIGURE 4

Pharmaceutical innovation (development of NMEs) as a function of prescription drug spending (N = 288): 2000.

Note. NME = new molecular entity. Axes are on a log scale. Countries above the line develop a higher percentage of drugs compared with their percentage contribution to prescription drug spending.